Enterprise Value
712M
Cash
564M
Avg Qtr Burn
N/A
Short % of Float
17.66%
Insider Ownership
25.67%
Institutional Own.
76.16%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
TCER® IMA402 (PRAME) Details Solid tumor/s, Cancer | Phase 1/2 Data readout | |
ACTengine® IMA203 GEN2 (PRAME) Details Melanoma, Cancer, Solid tumor/s Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 1b Data readout | |
ACTengine® IMA203 GEN1 (PRAME) Details Cancer, Solid tumor/s, Melanoma | Phase 1b Data readout | |
TCER® IMA401 (MAGEA4/8) Details Cancer, Solid tumor/s | Phase 1 Data readout | |
ACTengine IMA201 Details Solid tumor/s, Cancer | Failed Discontinued | |
ACTengine IMA202 Details Cancer, Solid tumor/s | Failed Discontinued |